Share on StockTwits
 

Equities research analysts at FBR Capital Markets lifted their price objective on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) from $16.00 to $18.00 in a research note issued to investors on Friday, Analyst Ratings Net reports. The firm currently has a “market perform” rating on the stock. FBR Capital Markets’ price target would suggest a potential downside of 1.10% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at Robert W. Baird raised their price target on shares of Allscripts Healthcare Solutions from $20.00 to $23.00 in a research note on Friday. Separately, analysts at Leerink Swann raised their price target on shares of Allscripts Healthcare Solutions from $18.00 to $23.00 in a research note on Friday. Finally, analysts at Citigroup Inc. initiated coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday. They set a “neutral” rating on the stock. Nine analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $18.08.

Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 6.50% during mid-day trading on Friday, hitting $18.34. 8,608,193 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a one year low of $12.02 and a one year high of $18.87. The stock has a 50-day moving average of $16.33 and a 200-day moving average of $15.21. The company’s market cap is $3.268 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, February 20th. The company reported $0.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.08. The company had revenue of $351.00 million for the quarter, compared to the consensus estimate of $343.47 million. Analysts expect that Allscripts Healthcare Solutions will post $0.44 EPS for the current fiscal year.

Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.